JP2008514209A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2008514209A5 JP2008514209A5 JP2007533908A JP2007533908A JP2008514209A5 JP 2008514209 A5 JP2008514209 A5 JP 2008514209A5 JP 2007533908 A JP2007533908 A JP 2007533908A JP 2007533908 A JP2007533908 A JP 2007533908A JP 2008514209 A5 JP2008514209 A5 JP 2008514209A5
- Authority
- JP
- Japan
- Prior art keywords
- numb
- cancer
- patient
- sample
- kit
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GBGB0421838.4A GB0421838D0 (en) | 2004-09-30 | 2004-09-30 | Cancer markers |
| PCT/EP2005/010153 WO2006037462A2 (en) | 2004-09-30 | 2005-09-20 | Cancer markers |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2008514209A JP2008514209A (ja) | 2008-05-08 |
| JP2008514209A5 true JP2008514209A5 (https=) | 2008-10-16 |
Family
ID=33427903
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2007533908A Pending JP2008514209A (ja) | 2004-09-30 | 2005-09-20 | 癌マーカー |
Country Status (7)
| Country | Link |
|---|---|
| US (1) | US7901876B2 (https=) |
| EP (2) | EP1802971A2 (https=) |
| JP (1) | JP2008514209A (https=) |
| AU (1) | AU2005291613A1 (https=) |
| CA (1) | CA2581041A1 (https=) |
| GB (1) | GB0421838D0 (https=) |
| WO (1) | WO2006037462A2 (https=) |
Families Citing this family (17)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6984522B2 (en) | 2000-08-03 | 2006-01-10 | Regents Of The University Of Michigan | Isolation and use of solid tumor stem cells |
| US8747867B2 (en) | 2004-09-30 | 2014-06-10 | Ifom Fondazione Instituto Firc Di Oncologia Molecolare | Cancer markers |
| ES2413087T3 (es) | 2006-06-13 | 2013-07-15 | Oncomed Pharmaceuticals, Inc. | Composiciones y métodos para el diagnóstico y tratamiento del cáncer |
| WO2008092002A2 (en) | 2007-01-24 | 2008-07-31 | The Regents Of The University Of Michigan | Compositions and methods for treating and diagnosing pancreatic cancer |
| WO2008091641A2 (en) | 2007-01-24 | 2008-07-31 | Oncomed Pharmaceuticals, Inc. | Compositions and methods for diagnosing and treating cancer |
| US20090208491A1 (en) * | 2007-02-14 | 2009-08-20 | Austin Gurney | Compositions and Methods for Diagnosing and Treating Cancer |
| JP2010520280A (ja) * | 2007-03-05 | 2010-06-10 | ボード オブ リージェンツ， ザ ユニバーシティ オブ テキサス システム | ＮｏｔｃｈまたはＮｕｍｂ特異的免疫療法との相乗効果を有する、癌細胞の再生のネガティブな遺伝的制御 |
| US8119366B2 (en) * | 2007-10-05 | 2012-02-21 | Trojan Technologies, Ltd. | Antennapedia-dominant negative mastermind-like construct |
| CN102112490B (zh) | 2008-07-08 | 2014-10-22 | 昂考梅德药品有限公司 | Notch1受体结合剂和其使用方法 |
| US9132189B2 (en) | 2008-07-08 | 2015-09-15 | Oncomed Pharmaceuticals, Inc. | Notch1 binding agents and methods of use thereof |
| US9173963B2 (en) | 2009-05-14 | 2015-11-03 | Duke University | Diagnostic and treatment for chronic and acute phase myeloid leukemia |
| MX2012008085A (es) | 2010-01-13 | 2012-09-12 | Oncomed Pharm Inc | Agentes de union notch1 y metodos de uso de los mismos. |
| WO2013155077A1 (en) * | 2012-04-09 | 2013-10-17 | Board Of Regents,The University Of Texas System | Response markers for src inhibitor therapies |
| CN112472699A (zh) | 2013-07-26 | 2021-03-12 | 种族肿瘤学公司 | 改善比生群及衍生物的治疗益处的组合方法 |
| US10746740B2 (en) | 2015-01-22 | 2020-08-18 | Konica Minolta, Inc. | Biological substance quantitation method, pathological diagnosis support system, and recording medium storing computer readable program |
| CN109266740A (zh) * | 2017-07-14 | 2019-01-25 | 中国科学院上海生命科学研究院 | 用于肺癌诊断或预后的标志物及诊断试剂 |
| CN114606320B (zh) * | 2022-04-13 | 2023-06-16 | 重庆医科大学 | 生物标志物epn3在制备诊断或评估肺癌的产品中的应用 |
Family Cites Families (22)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE3380777D1 (en) | 1982-08-27 | 1989-11-30 | Roger Philip Ekins | Measurement of analyte concentration |
| AU614935B2 (en) | 1986-08-06 | 1991-09-19 | Multilyte Limited | Determination of analyte concentration using two labelling markers |
| GB8803000D0 (en) | 1988-02-10 | 1988-03-09 | Ekins Roger Philip | Determination of ambient concentrations of several analytes |
| GB8810400D0 (en) | 1988-05-03 | 1988-06-08 | Southern E | Analysing polynucleotide sequences |
| GB9015198D0 (en) | 1990-07-10 | 1990-08-29 | Brien Caroline J O | Binding substance |
| AU2872092A (en) | 1991-10-15 | 1993-05-21 | Multilyte Limited | Binding assay employing labelled reagent |
| GB9326451D0 (en) | 1993-12-24 | 1994-02-23 | Multilyte Ltd | Binding assay |
| GB9326450D0 (en) | 1993-12-24 | 1994-02-23 | Multilyte Ltd | Binding assay |
| GB9404709D0 (en) | 1994-03-11 | 1994-04-27 | Multilyte Ltd | Binding assay |
| GB9815799D0 (en) | 1998-07-21 | 1998-09-16 | Pharmagene Lab Limited | Quantitative analysis of gene expression |
| EP1117778A2 (en) * | 1998-10-02 | 2001-07-25 | THE GOVERNMENT OF THE UNITED STATES OF AMERICA, as represented by THE SECRETARY, DEPARTMENT OF HEALTH AND HUMAN SERVICES | Methods and compositions for inducing differentiation and apoptosis in cells that overexpress the notch protein |
| US6984522B2 (en) * | 2000-08-03 | 2006-01-10 | Regents Of The University Of Michigan | Isolation and use of solid tumor stem cells |
| FR2818747B1 (fr) | 2000-12-26 | 2003-05-16 | Molecular Engines Laboratoires | Procede de criblage base sur l'interaction siah-numb |
| EP1410011B1 (en) | 2001-06-18 | 2011-03-23 | Rosetta Inpharmatics LLC | Diagnosis and prognosis of breast cancer patients |
| US7171311B2 (en) | 2001-06-18 | 2007-01-30 | Rosetta Inpharmatics Llc | Methods of assigning treatment to breast cancer patients |
| EP1410018A1 (en) | 2001-07-25 | 2004-04-21 | Lorantis Limited | Method for detecting modultators of notch signalling |
| WO2003042246A2 (en) * | 2001-11-14 | 2003-05-22 | Lorantis Limited | Inhibitors of the notch signalling pathway for use in the treatment of cancer |
| AU2003223661A1 (en) | 2002-04-15 | 2003-11-03 | Rigel Pharmaceuticals, Inc. | Methods of assaying for cell cycle modulators |
| US20050272061A1 (en) | 2004-02-19 | 2005-12-08 | Seattle Genetics, Inc. | Expression profiling in non-small cell lung cancer |
| US7837993B2 (en) * | 2004-03-19 | 2010-11-23 | The Board Of Trustees Of The Leland Stanford Junior University | Methods and compositions for regeneration of aged skeletal muscle tissues |
| WO2006034278A2 (en) * | 2004-09-21 | 2006-03-30 | Matritech, Inc. | Methods and compositions for detecting cancer using components of the u2 spliceosomal particle |
| AU2006259583A1 (en) | 2005-06-13 | 2006-12-28 | The Regents Of The University Of Michigan | Compositions and methods for treating and diagnosing cancer |
-
2004
- 2004-09-30 GB GBGB0421838.4A patent/GB0421838D0/en not_active Ceased
-
2005
- 2005-09-20 US US11/664,137 patent/US7901876B2/en not_active Expired - Fee Related
- 2005-09-20 WO PCT/EP2005/010153 patent/WO2006037462A2/en not_active Ceased
- 2005-09-20 AU AU2005291613A patent/AU2005291613A1/en not_active Abandoned
- 2005-09-20 CA CA002581041A patent/CA2581041A1/en not_active Abandoned
- 2005-09-20 EP EP05787481A patent/EP1802971A2/en not_active Withdrawn
- 2005-09-20 JP JP2007533908A patent/JP2008514209A/ja active Pending
- 2005-09-20 EP EP10006758A patent/EP2249155A3/en not_active Withdrawn
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| González‐Gualda et al. | A guide to assessing cellular senescence in vitro and in vivo | |
| JP2008514209A5 (https=) | ||
| Berends et al. | Biochemical and biophysical assessment of MTX‐induced liver fibrosis in psoriasis patients: Fibrotest predicts the presence and Fibroscan® predicts the absence of significant liver fibrosis | |
| US10883956B2 (en) | Electrochemical sensor for analyte detection | |
| JP2021007416A (ja) | 細胞全体でのアッセイおよび方法 | |
| JP7264484B2 (ja) | 治療剤選択のためのシグナル伝達経路活性の測定方法 | |
| Cho et al. | Endometrial osteopontin mRNA expression and plasma osteopontin levels are increased in patients with endometriosis | |
| JP2010539508A5 (https=) | ||
| RU2014112348A (ru) | Способ детекции нуклеосом, содержащих гистоновые варианты | |
| JP2014529405A5 (https=) | ||
| JP2019534321A5 (https=) | ||
| JP2023505526A (ja) | Ｒａｓノード標的化治療剤またはｒｔｋ標的化治療剤を用いてがん患者を処置する方法 | |
| Marshall et al. | Strategies for biomarker discovery in fibrotic disease | |
| Zhou et al. | Improved detection of HER2 by a quasi-targeted proteomics approach using aptamer–peptide probe and liquid chromatography–tandem mass spectrometry | |
| KR20190039089A (ko) | 결장직장암에 대한 복합 테스트 | |
| JP2023539867A5 (https=) | ||
| JP2018529931A (ja) | 喀痰試料中のバイオマーカーとしての細胞外遊離ヌクレオソームの使用 | |
| JP2018529931A5 (https=) | ||
| Fernandez et al. | Tissue age affects antigenicity and scoring for the 22C3 immunohistochemistry companion diagnostic test | |
| Ibrahim et al. | Differentiating active from stable vitiligo: the role of dermoscopic findings and their relation to CXCL10 | |
| Mukherjee et al. | In-cell Western™ detection of organic cation transporters in bronchial epithelial cell layers cultured at an air–liquid interface on Transwell® inserts | |
| Devarajan | The promise of biomarkers for personalized renal cancer care | |
| Shin et al. | What is the appropriate cut-off value of CRP to predict endoscopic remission in patients with ulcerative colitis in clinical remission? | |
| Cho et al. | Diagnostic and prognostic impact of osteopontin expression in endometrial cancer | |
| Hu et al. | From traditional biomarkers to transcriptome analysis in drug development |